Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

EFPIA says “indiscriminate” data transparency could be harmful

Comments come as European Parliament prepares to discuss clinical trial overhaul

- PMLiVE

Publicis Groupe gives its VivaKi agencies greater autonomy

Move intended to boost Groupe’s digital growth as its third quarter revenues fall

- PMLiVE

A brain of two halves

The commonly held view that a campaign has to deliver cold hard facts with an appealing visual may be an oversimplification…

- PMLiVE

Lindsay Rocco to lead corporate communications at Dendreon

Joins from agency Rx Mosaic Health

- PMLiVE

Behavioural economics in pharma

It’s not the answer to life’s big question but gives us the framework we need to understand decision making

- PMLiVE

WHO launches framework to monitor non-communicable diseases

Will measure success of efforts to reduce rates of cancer, diabetes, lung conditions and heart disease

Government accused of blocking patients from drug pricing talks

Coalition of cancer charities calls for a central role in pricing negotiations

Cancer Research UK appoints new head of public affairs and campaigning

Layla Theiner will drive the charity’s public affairs and campaigning activities across the UK and EU

- PMLiVE

Medicines key to new NHS Mandate, says ABPI

Government sets objectives for NHS Commissioning Board to improve patient care in England

Roche, social media and patients – part 1

UK pharma company talks about its digital patient group summit Share+

- PMLiVE

Merck & Co stops development of Januvia, atorvastatin combo

Company spokesperson claims decision is for “business reasons”

german flag

AZ sees Seroquel XR patent overturned in Germany

Follows challenge by Teva, Hexal and Accord Healthcare

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links